
Nephrostomy Bags Market Report 2026
Global Outlook – By Type (Sterile, Non-sterile), By Material (Polyvinyl Chloride (PVC) And Polyurethane (PU), Silicone, Others Materials), By Usage (Disposable, Reusable), By Capacity (100-500 Milliliters (ml), 500-1000 Milliliters (ml), Above 1000 Milliliters (ml)), By End-User (Hospitals And Clinics, Homecare, Ambulatory Surgical Centers, Others End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Nephrostomy Bags Market Overview
• Nephrostomy Bags market size has reached to $1.16 billion in 2025 • Expected to grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: Increasing Prevalence Of Surgical Procedures Fueling The Growth Of The Market Due To Rising Urological Surgeries And Postoperative Drainage Needs • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Nephrostomy Bags Market?
Nephrostomy bags are external medical devices that collect urine directly from the kidneys when normal urine flow is blocked. They are connected to a nephrostomy tube, which is surgically inserted through the skin into the kidney. Nephrostomy bags safely drain urine in cases of urinary tract obstruction due to kidney stones, tumors, or infections. The main types in the nephrostomy bags are sterile and non-sterile. Sterile nephrostomy bags refer to urinary drainage bags that are manufactured and packaged in a sterile environment to ensure they are free from bacteria, viruses, and other microorganisms. The various materials include polyvinyl chloride (PVC) and polyurethane, silicone, and other materials. The usage types are disposable and reusable. The different capacities are 100-500 milliliters (ml), 500-1000 milliliters (ml), and above 1000 milliliters (ml). The different end-users include hospitals and clinics, home care, ambulatory surgical centers, and other end-users.
What Is The Nephrostomy Bags Market Size and Share 2026?
The nephrostomy bags market size has grown strongly in recent years. It will grow from $1.16 billion in 2025 to $1.25 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising incidence of urinary tract obstructions, increasing prevalence of kidney stone disorders, expansion of hospital-based urology procedures, availability of sterile drainage solutions, growing use of nephrostomy interventions.What Is The Nephrostomy Bags Market Growth Forecast?
The nephrostomy bags market size is expected to see strong growth in the next few years. It will grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing geriatric population with renal disorders, rising demand for home-based post-operative care, growing awareness of infection prevention products, expansion of minimally invasive urology procedures, increasing healthcare expenditure on drainage devices. Major trends in the forecast period include increasing adoption of anti-reflux nephrostomy bags, rising demand for silicone-based collection bags, growing preference for disposable nephrostomy solutions, expansion of homecare-based urinary drainage management, enhanced focus on patient comfort and infection control.Global Nephrostomy Bags Market Segmentation
1) By Type: Sterile, Non-sterile 2) By Material: Polyvinyl Chloride (PVC) And Polyurethane (PU), Silicone, Others Materials 3) By Usage: Disposable, Reusable 4) By Capacity: 100-500 Milliliters (ml), 500-1000 Milliliters (ml), Above 1000 Milliliters (ml) 5) By End-User: Hospitals And Clinics, Homecare, Ambulatory Surgical Centers, Others End Users Subsegments: 1) By Sterile: Closed Drainage Bags, Anti-Reflux Nephrostomy Bags, Single-Use Sterile Bags 2) By Non-Sterile: Open Drainage Bags, Reusable Non-Sterile Bags, Economy Nephrostomy BagsWhat Are The Drivers Of The Nephrostomy Bags Market?
The increasing prevalence of surgical procedures is expected to propel the growth of the nephrostomy bags market going forward. Surgical procedures are medical interventions involving manual or instrumental techniques to treat diseases, injuries, or deformities. The increasing prevalence of surgical procedures is due to the rising incidence of urological conditions such as kidney stones, tumors, and urinary tract obstructions that often require surgical intervention for effective treatment. Nephrostomy bags support surgical procedures by providing effective postoperative urine drainage, reducing complications from urinary obstructions. They enhance patient recovery by preventing infection, minimizing pressure on the kidneys, and improving overall care in hospital and home settings. For instance, in September 2023, according to the American Society of Plastic Surgeons (ASPS), a US-based medical association, liposuction surgery (a cosmetic procedure that removes excess fat from specific areas of the body) reached 347,782 procedures in 2023, marking a 7% increase from 2022. Therefore, the increasing prevalence of surgical procedures drives the growth of the nephrostomy bags industry. The rising prevalence of kidney diseases is expected to propel the growth of the nephrostomy bags market going forward. Kidney diseases are conditions that damage the kidneys and reduce their ability to filter waste, balance fluids, and maintain overall health. Kidney diseases are increasing mainly due to the rising prevalence of diabetes, which damages the kidneys and impairs their ability to filter waste. Nephrostomy bags support kidney disease management by safely collecting urine when kidney drainage is blocked, reducing the risk of infection and kidney damage. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, over 14% of US adults, around 35.5 million people, are estimated to have chronic kidney disease (CKD), yet up to 90% of those with the condition are unaware of it. Even among adults with severe chronic kidney disease, about one in three remain undiagnosed. Therefore, the rising prevalence of kidney diseases is driving the growth of the nephrostomy bags industry. The rising preference for minimally invasive procedures is expected to propel the growth of the nephrostomy bags market going forward. Minimally invasive procedures refer to medical techniques that involve smaller incisions or no incisions at all, aiming to reduce trauma to the body compared to traditional open surgery. The rising preference for minimally invasive procedures is attributed to reduced recovery time, lower risk of complications, minimal scarring, and improved patient outcomes compared to traditional surgical methods. Nephrostomy bags support minimally invasive procedures by enabling urine drainage without open surgery, reducing complications and promoting faster recovery. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based medication company, reported that in 2023, minimally invasive procedures grew by 7%, outpacing surgical procedures, with over 9 million neuromodulator injections and 5 million hyaluronic acid fillers. Therefore, the rising preference for minimally invasive procedures is driving the growth of the nephrostomy bags industry.Key Players In The Global Nephrostomy Bags Market
Major companies operating in the nephrostomy bags market are Coloplast, Teleflex Incorporated, Hollister Incorporated, Merit Medical Systems Inc., B. Braun Melsungen AG, Sanxin Medical, Remington Medical Inc., UreSil LLC, Rufa Products, Lifevv, Becton Dickinson and Company, Cook Medical, Boston Scientific, AngioDynamics Inc., WellLead Medical Co. Ltd., PFM Medical AG, Convatec Group plc, Flexicare Medical Ltd., Medline Industries LP, Sterimed Medical Devices Pvt. Ltd.Regional Outlook
North America was the largest region in the nephrostomy bags market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Nephrostomy Bags Market?
The nephrostomy bags market consists of sales of standard drainage bags, anti-reflux nephrostomy bags, disposable and reusable bags, leg-mounted and bedside bags, as well as accessories such as tubing, connectors, and securement devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Nephrostomy Bags Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.25 billion |
| Revenue Forecast In 2035 | $1.65 billion |
| Growth Rate | CAGR of 7.4% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Material, Usage, Capacity, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Coloplast, Teleflex Incorporated, Hollister Incorporated, Merit Medical Systems Inc., B. Braun Melsungen AG, Sanxin Medical, Remington Medical Inc., UreSil LLC, Rufa Products, Lifevv, Becton Dickinson and Company, Cook Medical, Boston Scientific, AngioDynamics Inc., WellLead Medical Co. Ltd., PFM Medical AG, Convatec Group plc, Flexicare Medical Ltd., Medline Industries LP, Sterimed Medical Devices Pvt. Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
